These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24739070)

  • 21. Pharmacokinetics of levetiracetam in neonates with seizures.
    Merhar SL; Schibler KR; Sherwin CM; Meinzen-Derr J; Shi J; Balmakund T; Vinks AA
    J Pediatr; 2011 Jul; 159(1):152-154.e3. PubMed ID: 21592494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of levetiracetam after oral and intravenous administration of a single dose to clinically normal cats.
    Carnes MB; Axlund TW; Boothe DM
    Am J Vet Res; 2011 Sep; 72(9):1247-52. PubMed ID: 21879984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum levetiracetam concentrations and adverse events after multiple dose extended release levetiracetam administration to healthy cats.
    Barnes Heller H; Granick M; Van Hesteren M; Boothe DM
    J Vet Intern Med; 2018 May; 32(3):1145-1148. PubMed ID: 29671898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
    Patsalos PN
    Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus.
    Frucht SJ; Louis ED; Chuang C; Fahn S
    Neurology; 2001 Sep; 57(6):1112-4. PubMed ID: 11571347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study.
    Delanty N; Jones J; Tonner F
    Epilepsia; 2012 Jan; 53(1):111-9. PubMed ID: 22050371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic drug monitoring of levetiracetam].
    Dailly E; Bouquié R; Bentué-Ferrer D;
    Therapie; 2010; 65(1):67-70. PubMed ID: 20205999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic study of levetiracetam in children.
    Pellock JM; Glauser TA; Bebin EM; Fountain NB; Ritter FJ; Coupez RM; Shields WD
    Epilepsia; 2001 Dec; 42(12):1574-9. PubMed ID: 11879369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
    Dooley M; Plosker GL
    Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests.
    Brockmöller J; Thomsen T; Wittstock M; Coupez R; Lochs H; Roots I
    Clin Pharmacol Ther; 2005 Jun; 77(6):529-41. PubMed ID: 15961984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetic characteristics of levetiracetam.
    Patsalos PN
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):123-9. PubMed ID: 12731458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probable levetiracetam-associated depression in the elderly: two case reports.
    Vande Griend JP; Linnebur SA; Bainbridge JL
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):281-4. PubMed ID: 19948304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population pharmacokinetics of levetiracetam in neonates with seizures.
    Lima-Rogel V; López-López EJ; Medellín-Garibay SE; Gómez-Ruiz LM; Romero-Méndez C; Milán-Segovia RC; Romano-Moreno S
    J Clin Pharm Ther; 2018 Jun; 43(3):422-429. PubMed ID: 29265480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: dosing recommendations.
    Toublanc N; Sargentini-Maier ML; Lacroix B; Jacqmin P; Stockis A
    Clin Pharmacokinet; 2008; 47(5):333-41. PubMed ID: 18399714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Review on Pharmacokinetics of Levetiracetam in Neonates.
    Agrawal A; Banergee A
    Curr Drug Metab; 2017 Oct; 18(8):727-734. PubMed ID: 28595534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Separate episodes of delirium associated with levetiracetam and amiodarone treatment in an elderly woman.
    Foley KT; Bugg KS
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):170-4. PubMed ID: 20439066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration.
    Van Matre ET; Mueller SW; Fish DN; MacLaren R; Cava LF; Neumann RT; Kiser TH
    Am J Case Rep; 2017 Apr; 18():458-462. PubMed ID: 28446744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Levetiracetam: an anti-epileptic drug with interesting pharmacokinetic properties].
    Wagner GL; Wilms EB; Vecht ChJ
    Ned Tijdschr Geneeskd; 2002 Jun; 146(26):1218-21. PubMed ID: 12132136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levetiracetam-induced leukocytoclastic vasculitis.
    Gupta M
    Indian J Pharmacol; 2017; 49(1):124-126. PubMed ID: 28458437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.